PTH-(7-84) exerts differential global gene expression compared to PTH-(1-84) in cultured human osteoclasts.

被引:0
|
作者
Chris, M [1 ]
Langub, D [1 ]
Li, H [1 ]
Stromberg, A [1 ]
Malluche, HH [1 ]
Koszewski, NJ [1 ]
机构
[1] Univ Kentucky, Lexington, KY USA
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2003年 / 14卷
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:686A / 686A
页数:1
相关论文
共 41 条
  • [21] RESPONSE OF THE PARATHYROID-GLAND TO INFUSION OF HUMAN PARATHYROID HORMONE-(1-34) [PTH-(1-34)] - DEMONSTRATION OF SUPPRESSION OF ENDOGENOUS SECRETION USING IMMUNORADIOMETRIC INTACT PTH-(1-84) ASSAY
    COSMAN, F
    SHEN, V
    HERRINGTON, B
    LINDSAY, R
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 73 (06): : 1345 - 1351
  • [22] Opposite effects of calcitriol and paricalcitol on the PTH-(1-84)/ C-large fragment ratio in patients on hemodialysis.
    Faugere, MCM
    Mawad, HW
    Trueba, DM
    Friedler, RM
    Malluche, HH
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 686A - 686A
  • [23] The utility of the 1-84 PTH (CAP)/7-84 PTH (CIP) ratio to accurately discriminate adynamic bone disease from high bone turnover disease with similar 1-84 PTH values, as demonstrated with bone histology
    Cantor, T
    Tokumoto, A
    Amerling, R
    CLINICAL CHEMISTRY, 2005, 51 : A235 - A235
  • [24] Long term use of 1-84 PTH/7-84 PTH ratio avoids adynamic bone disease in African American hemodialysis patients.
    Cantor, T. L.
    Fehmi, H.
    Daramola, O.
    Osman, Y.
    Nguyen, K.
    Yee, J.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S87 - S87
  • [25] ARTICULAR CHONDROCYTES LOSE THEIR PROLIFERATIVE ACTIVITY WITH AGING YET CAN BE RESTIMULATED BY PTH-(1-84), PGE1, AND DEXAMETHASONE
    LIVNE, E
    WEISS, A
    SILBERMANN, M
    JOURNAL OF BONE AND MINERAL RESEARCH, 1989, 4 (04) : 539 - 548
  • [26] Determination of selective parathyroid secretion of 1-84 PTH alone or together with 7-84 PTH_implications for renal bone disease therapeutic strategies
    Cantor, T
    Fulla, Y
    Vuillemard, C
    Nonnemacher, L
    Legmann, P
    Bonnichon, P
    Chapuis, Y
    CLINICAL CHEMISTRY, 2005, 51 : A238 - A238
  • [27] Changes in intact PTH, 1-84 PTH/7-84 PTH and the calcium x phosphate product following 5 months of cinacalcet therapy in 13 ESRD patients.
    Cantor, TL
    Amerling, R
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S308 - S308
  • [28] Intravenous vitamin D therapy reduces PTH-(1-84)/large C fragments ratio in chronic hemodialysis patients
    Kihara, T
    Ichikawa, H
    Morimoto, H
    Yano, A
    Akagi, S
    Nakao, K
    Kohmoto, H
    Wada, J
    Kumagai, I
    Makino, H
    NEPHRON CLINICAL PRACTICE, 2004, 98 (03): : C93 - C100
  • [29] How the use of the 1-84 PTH (CAP)/7-84 PTH (CIP) ratio benefited our dialysis patients in the control of calcium x phosphate levels
    Cantor, T
    Amerling, R
    CLINICAL CHEMISTRY, 2005, 51 : A235 - A236
  • [30] Amino terminal cleavage of PTH(1-84) to PTH(7-84) is regulated by serum calcium concentration via calcium-sensing receptor in hemodialysis patients
    Koshikawa, Masao
    Nishiguchi, Kensuke
    Yorifuji, Soshi
    Shimazu, Keiji
    Takaori, Koji
    Mori, Keita
    Eguchi, Eriko
    Okada, Kikuo
    Tanaka, Atsuo
    Kuwahara, Takashi
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2010, 14 (03) : 233 - 238